82 related articles for article (PubMed ID: 7958065)
1. Interleukin-3 in gene therapy of cancer.
McBride WH; Dougherty GD; Wallis AE; Economou JS; Chiang CS
Folia Biol (Praha); 1994; 40(1-2):62-73. PubMed ID: 7958065
[TBL] [Abstract][Full Text] [Related]
2. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
[TBL] [Abstract][Full Text] [Related]
3. Combining radiation therapy with interleukin-3 gene immunotherapy.
Chiang CS; Hong JH; Wu YC; McBride WH; Dougherty GJ
Cancer Gene Ther; 2000 Aug; 7(8):1172-8. PubMed ID: 10975678
[TBL] [Abstract][Full Text] [Related]
4. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
5. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2.
Hiura M; Hashimura T; Watanabe Y; Kuribayashi K; Yoshida O
Folia Biol (Praha); 1994; 40(1-2):49-61. PubMed ID: 7958064
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.
Ogawa F; Iinuma H; Okinaga K
Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052
[TBL] [Abstract][Full Text] [Related]
7. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
[TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
Ohno K; Yoshizawa H; Tsukada H; Takeda T; Yamaguchi Y; Ichikawa K; Maruyama Y; Suzuki Y; Suzuki E; Arakawa M
J Immunol; 1996 May; 156(10):3875-81. PubMed ID: 8621926
[TBL] [Abstract][Full Text] [Related]
9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral IL-12 gene transfer improves the therapeutic efficacy of IL-12 but not IL-19.
Sobota V; Bubeník J; Símová J; Jandlová T
Folia Biol (Praha); 2000; 46(5):191-3. PubMed ID: 11055798
[TBL] [Abstract][Full Text] [Related]
11. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of cytokine gene expression during the in vitro CTL induction against a murine nonimmunogenic tumor.
Murata S; Eguchi Y; Mekata E; Tani T; Kodama M
Anticancer Res; 2000; 20(1A):363-72. PubMed ID: 10769681
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
[TBL] [Abstract][Full Text] [Related]
15. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM
Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
[TBL] [Abstract][Full Text] [Related]
16. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
17. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
18. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
19. Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.
Whelan MC; Casey G; MacConmara M; Lederer JA; Soden D; Collins JK; Tangney M; O'Sullivan GC
Cancer Gene Ther; 2010 Jul; 17(7):501-11. PubMed ID: 20186173
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
